Evaluation of Emotional Status and Coronary Flow Characteristics by TIMI Frame Count Method

NCT02831153 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2000

Last updated 2016-07-13

No results posted yet for this study

Summary

This study evaluates the effects of emotional status on coronary flow in patients undergoing elective coronary angiography. Patients whom undergoing elective coronary angiography will fulfill the Beck Anxiety Inventory, Beck Depression Inventory, State-Trait Anxiety Inventory, Hospital Anxiety and Depression Scale. State Anxiety Inventory will be fulfilled both before the intervention and after 1 hour the patients learned the results of the coronary angiography. The other scales will be performed after 1 hour the patients learned their results. Coronary flow will be assessed by TIMI (Thrombolysis In Myocardial Infarction) frame count method.

Conditions

Interventions

PROCEDURE

coronary angiography

Coronary angiography will be performed by transfemoral or transradial approach in all patients. In order to evaluate each coronary artery, at least four views from the left and two views from the right system will be taken.

Sponsors & Collaborators

  • Abant Izzet Baysal University

    collaborator OTHER
  • Saglik Bilimleri Universitesi Gulhane Tip Fakultesi

    collaborator OTHER
  • Ankara City Hospital Bilkent

    collaborator OTHER
  • Private Yenisehir Hospital

    collaborator UNKNOWN
  • Private Gozde Hospital

    collaborator UNKNOWN
  • Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital

    collaborator OTHER
  • Ertan YETKIN

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
TRIPLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2017-07-31
Completion
2017-07-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02831153 on ClinicalTrials.gov